NAD+-dependent deacetylase SIRT2 is extensively involved in tumor progression, playing drastically different roles in various tumor models, dictated by the substrate(s) of SIRT2 deacetylase activity 27, 34-36. The gene discussed is SIRT2; the disease is neoplasm.